Patents by Inventor Tobias V. Lanz

Tobias V. Lanz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTICS AND THERAPEUTICS FOR EBV IN MS AND OTHER AUTOIMMUNE DISEASES
    Publication number: 20240309451
    Abstract: Compositions and methods are provided for diagnosis and treatment of individuals having multiple sclerosis (MS) or MS spectrum disorders. It is shown herein that EBV-transformed B cells, and particularly plasmablasts, are present in human MS spinal fluid. These cells produce antibodies. e.g. IgG antibodies, that selectively bind to EBV EBNA-1 sequences, including without limitation residues 386-405, and cross-react with the myelin protein hepacam/glialcam, including without limitation residues 337-385.
    Type: Application
    Filed: December 23, 2021
    Publication date: September 19, 2024
    Inventors: William H. Robinson, Tobias V. Lanz
  • TARGETED REDUCTION OF ACTIVATED IMMUNE CELLS
    Publication number: 20240239912
    Abstract: The present invention relates to novel bi-specific antigen-binding polypeptides and their preparation and use in the treatment and/or diagnosis of various diseases, and also relates to bi-specific antibody molecules capable of inhibiting immune effector cells and their use in diagnosis and/or treatment of various diseases.
    Type: Application
    Filed: April 9, 2021
    Publication date: July 18, 2024
    Inventors: William H. Robinson, Tobias V. Lanz, Samuel J. Rubin